- Specialization
- Not classified
- Business
- Software Applications
- Market
- Healthcare
- Ecosystem
- Agents
- Customers
- Enterprises
More details
- Organization type
- Commercial Company
- Ecosystem
- Agents
- Business
- Software Applications
- Specialization
- Not classified
- Market
- Healthcare
- Customers
- Enterprises
- Delivery models
- Not classified
- Revenue models
- Not classified
- Listing status
- Not classified
- Latest equity round
- Not classified
- Reported funding amount
- Not classified
About
CombineHealth builds AI agents for healthcare organizations’ revenue-cycle operations, covering workflows from eligibility verification and medical coding through claim submission, payment posting, reconciliation, and denial management. Its differentiation is payer-aware automation that learns from insurance interactions as payer rules evolve.
Market
CombineHealth competes in the AI-powered healthcare revenue-cycle management market, spanning eligibility, coding, billing, claims, payment posting, accounts receivable, and denial management. It positions itself as an AI workforce of agents that executes revenue-cycle workflows end to end, learns from insurance interactions, and integrates with existing systems. Relative to coding-focused competitors such as CodaMetrix, Nym, and Fathom, its differentiation is broader workflow coverage and a more autonomous, explainable approach; AKASA, Infinx, and Adonis are the closest broader RCM-automation comparisons.
CombineHealth targets healthcare provider organizations with labor-intensive revenue-cycle operations that need to reduce manual work, improve collections, and accelerate reimbursement. Its primary buyers and users are revenue-cycle leaders and functional teams such as medical coders, billers, eligibility specialists, and denial-management staff.
At a Glance
Problem
CombineHealth targets revenue leakage in healthcare revenue-cycle management, where providers lose money through denied or underpaid claims, coding and documentation gaps, and labor-intensive follow-up. The economic pain is substantial: one 2026 industry benchmark estimated that hospital denials reached 11.6% in 2025 and represented $48.4 billion in leakage. The clearest use case is denial and accounts-receivable management: teams must repeatedly navigate payer phone systems, track appeal deadlines, determine which claims are worth pursuing, and prevent the same root causes from recurring.
Product / Service
CombineHealth offers an end-to-end AI revenue-cycle platform built around agentic AI workers. Its scope spans eligibility and benefits verification, clinical documentation improvement, coding and charge capture, claims submission, denial prediction and appeals, payment posting, and A/R follow-up. The platform is designed to integrate with existing EHRs, practice-management systems, and clearinghouses rather than require providers to replace their core infrastructure. Its flagship denial-management worker, Adam, can call payers, navigate IVRs and live agents, summarize calls, track appeals, prioritize high-value claims, and feed payer outcomes back into upstream workflows.
The delivery model combines automation with human oversight. CombineHealth emphasizes explainable, policy-backed decisions and audit trails, while routing complex cases to human experts. The company markets benefits including cleaner claims, fewer denials, faster reimbursement, and lower manual workload; its website claims 97%+ coding accuracy and 85% less manual effort, while Adam's page cites a 15% increase in collections. These should be treated as company-reported performance claims rather than independently verified benchmarks.
Market
CombineHealth competes in healthcare information technology, specifically AI-enabled revenue-cycle management, medical coding, denial management, and payment optimization for hospitals, clinics, and other provider organizations. Its positioning is broader than a coding-only tool because it aims to automate the full revenue cycle. Overlapping alternatives include Fathom in AI medical coding, AGS Health's AI-enabled RCM and global service-delivery model, and full billing platforms such as Waystar and athenaCollector; traditional RCM vendors and internal billing teams are also substitutes.
The company was founded in 2022, joined Y Combinator's Winter 2023 batch, remains listed as active, and has roughly 15–16 employees across available profiles. PitchBook identifies Emergent Ventures and Y Combinator as investors, reports $500,000 raised, and labels the company as generating revenue, but its current-revenue field is blank and no quantified customer or revenue scale is disclosed in the evidence. The best-supported characterization is therefore an early-stage, venture-backed company with initial commercial traction—not clearly pre-revenue, but without publicly established scale.
Founders & Leadership
Funding History
Emergent Ventures
Recent News
CombineHealth published a CFO-focused checklist for evaluating AI medical-coding platforms, covering explainability, compliance, integration, governance, and pilot validation. The article also highlights the company’s Amy product and a reported 97% coding-accuracy result.
CombineHealth published guidance explaining that CO-116 claim denials can result when a patient’s Advance Beneficiary Notice does not meet regulatory requirements.
CombineHealth’s official integration page presents direct connectivity with existing EHR systems, while the company homepage lists integrations with major EHR and practice-management platforms including Epic, Greenway, NextGen, Oracle Cerner, and athenahealth.
CombineHealth’s product page promotes Amy as an autonomous medical-coding solution designed to automate coding, reduce denials, improve compliance, and streamline healthcare revenue-cycle workflows.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
CombineHealth’s apparent business model is B2B enterprise software: it sells an AI revenue-cycle automation platform to healthcare organizations through demo-driven sales. The available evidence does not disclose whether pricing is subscription-based, usage-based, or tied to recovered revenue.